Cargando…

A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection

Although generating high neutralizing antibody levels is a key component of protective immunity after acute viral infection or vaccination, little is known about why some individuals generate high versus low neutralizing antibody titers. Here, we leverage the high-dimensional single-cell profiling c...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Elizabeth E., Odorizzi, Pamela M., Lutz, Emma, Smullin, Carolyn P., Tenvooren, Iliana, Stone, Mars, Simmons, Graham, Hunt, Peter W., Feeney, Margaret E., Norris, Philip J., Busch, Michael P., Spitzer, Matthew H., Rutishauser, Rachel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151348/
https://www.ncbi.nlm.nih.gov/pubmed/35584677
http://dx.doi.org/10.1016/j.celrep.2022.110815
_version_ 1784717480381382656
author McCarthy, Elizabeth E.
Odorizzi, Pamela M.
Lutz, Emma
Smullin, Carolyn P.
Tenvooren, Iliana
Stone, Mars
Simmons, Graham
Hunt, Peter W.
Feeney, Margaret E.
Norris, Philip J.
Busch, Michael P.
Spitzer, Matthew H.
Rutishauser, Rachel L.
author_facet McCarthy, Elizabeth E.
Odorizzi, Pamela M.
Lutz, Emma
Smullin, Carolyn P.
Tenvooren, Iliana
Stone, Mars
Simmons, Graham
Hunt, Peter W.
Feeney, Margaret E.
Norris, Philip J.
Busch, Michael P.
Spitzer, Matthew H.
Rutishauser, Rachel L.
author_sort McCarthy, Elizabeth E.
collection PubMed
description Although generating high neutralizing antibody levels is a key component of protective immunity after acute viral infection or vaccination, little is known about why some individuals generate high versus low neutralizing antibody titers. Here, we leverage the high-dimensional single-cell profiling capacity of mass cytometry to characterize the longitudinal cellular immune response to Zika virus (ZIKV) infection in viremic blood donors in Puerto Rico. During acute ZIKV infection, we identify widely coordinated responses across innate and adaptive immune cell lineages. High frequencies of multiple activated cell types during acute infection are associated with high titers of ZIKV neutralizing antibodies 6 months post-infection, while stable immune features suggesting a cytotoxic-skewed immune set point are associated with low titers. Our study offers insight into the coordination of immune responses and identifies candidate cellular biomarkers that may offer predictive value in vaccine efficacy trials aimed at inducing high levels of antiviral neutralizing antibodies.
format Online
Article
Text
id pubmed-9151348
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-91513482022-05-31 A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection McCarthy, Elizabeth E. Odorizzi, Pamela M. Lutz, Emma Smullin, Carolyn P. Tenvooren, Iliana Stone, Mars Simmons, Graham Hunt, Peter W. Feeney, Margaret E. Norris, Philip J. Busch, Michael P. Spitzer, Matthew H. Rutishauser, Rachel L. Cell Rep Article Although generating high neutralizing antibody levels is a key component of protective immunity after acute viral infection or vaccination, little is known about why some individuals generate high versus low neutralizing antibody titers. Here, we leverage the high-dimensional single-cell profiling capacity of mass cytometry to characterize the longitudinal cellular immune response to Zika virus (ZIKV) infection in viremic blood donors in Puerto Rico. During acute ZIKV infection, we identify widely coordinated responses across innate and adaptive immune cell lineages. High frequencies of multiple activated cell types during acute infection are associated with high titers of ZIKV neutralizing antibodies 6 months post-infection, while stable immune features suggesting a cytotoxic-skewed immune set point are associated with low titers. Our study offers insight into the coordination of immune responses and identifies candidate cellular biomarkers that may offer predictive value in vaccine efficacy trials aimed at inducing high levels of antiviral neutralizing antibodies. 2022-05-17 /pmc/articles/PMC9151348/ /pubmed/35584677 http://dx.doi.org/10.1016/j.celrep.2022.110815 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
McCarthy, Elizabeth E.
Odorizzi, Pamela M.
Lutz, Emma
Smullin, Carolyn P.
Tenvooren, Iliana
Stone, Mars
Simmons, Graham
Hunt, Peter W.
Feeney, Margaret E.
Norris, Philip J.
Busch, Michael P.
Spitzer, Matthew H.
Rutishauser, Rachel L.
A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection
title A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection
title_full A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection
title_fullStr A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection
title_full_unstemmed A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection
title_short A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection
title_sort cytotoxic-skewed immune set point predicts low neutralizing antibody levels after zika virus infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151348/
https://www.ncbi.nlm.nih.gov/pubmed/35584677
http://dx.doi.org/10.1016/j.celrep.2022.110815
work_keys_str_mv AT mccarthyelizabethe acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT odorizzipamelam acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT lutzemma acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT smullincarolynp acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT tenvooreniliana acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT stonemars acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT simmonsgraham acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT huntpeterw acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT feeneymargarete acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT norrisphilipj acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT buschmichaelp acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT spitzermatthewh acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT rutishauserrachell acytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT mccarthyelizabethe cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT odorizzipamelam cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT lutzemma cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT smullincarolynp cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT tenvooreniliana cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT stonemars cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT simmonsgraham cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT huntpeterw cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT feeneymargarete cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT norrisphilipj cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT buschmichaelp cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT spitzermatthewh cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection
AT rutishauserrachell cytotoxicskewedimmunesetpointpredictslowneutralizingantibodylevelsafterzikavirusinfection